Award

Delivery Order #SPE2D326F124Q

Pfizer to Supply Tranexamic Acid Injection Under DLA Delivery Order

Buyer

Defense Logistics Agency

Award Amount

$134.76

Ceiling

$134.76

Awarded

May 15, 2026

Period of Performance

May 15, 2026 – May 18, 2026

Identifier

SPE2D326F124Q

NAICS

325412

This delivery order is placed under the Defense Logistics Agency’s long-term pharmaceutical supply agreement with Pfizer Inc., a pharmaceutical manufacturer. It procures Cyklokapron (tranexamic acid) injection, supplied as 1,000 mg in a 10 mL vial, for delivery in New York. The medicine is used to help control bleeding; the order supports access to pharmaceutical supplies for government medical needs. The scope shown is limited to this product and delivery, with no additional services or subcontractors reported. The order is associated with Pfizer’s parent indefinite-delivery contract for pharmaceutical manufacturing and distribution, which runs over a multi-year period. The parent award is described as competitively awarded; the order-level data does not specify whether this individual order involved a separate competition or a sole-source justification. The delivery order was recently issued for a brief performance period. No acquisition program or original solicitation details are provided.

Description

4571850221!CYKLOKAPRON 1,000 MG/10 ML VL 10ML

View original record